| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |